Sterling Pharma Solutions Acquires CiVentiChem US Facility in Cary, North Carolina

April 3, 2019

UK-based CDMO Sterling Pharma Solutions, a portfolio company of GHO Capital, has acquired the CiVentiChem US facility in Cary, North Carolina to establish a local presence for its North American clients and expand its chemistry development and kilo-scale cGMP capabilities. The acquisition supports Sterling’s strategy to build a global chemistry services business and follows GHO Capital’s majority investment in Sterling earlier this year.

Targets
CiVentiChem (US facility)
Sellers
CiVentiChem
Industry
Pharmaceuticals
Location
North Carolina, United States
Transaction Type
Addon

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.